Login to Your Account

Ardelyx potassium binder could KO Kayexalate

By Randy Osborne
Staff Writer

Tuesday, January 3, 2017

Although doing so isn’t necessary for the a 505(b)(2) regulatory pathway, Ardelyx Inc. is conducting phase II and phase III trials with its potassium binder to win a package insert that competes well, President and CEO Mike Raab noted.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription